FR1525M - Médicaments antiémétiques nouveaux. - Google Patents

Médicaments antiémétiques nouveaux.

Info

Publication number
FR1525M
FR1525M FR869011A FR869011A FR1525M FR 1525 M FR1525 M FR 1525M FR 869011 A FR869011 A FR 869011A FR 869011 A FR869011 A FR 869011A FR 1525 M FR1525 M FR 1525M
Authority
FR
France
Prior art keywords
antiemetic drugs
new
new antiemetic
drugs
antiemetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR869011A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority to FR869011A priority Critical patent/FR1525M/fr
Priority to FR897802A priority patent/FR36F/fr
Priority to GB2007962A priority patent/GB994023A/en
Priority to US210556A priority patent/US3219528A/en
Application granted granted Critical
Publication of FR1525M publication Critical patent/FR1525M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR869011A 1961-07-25 1961-07-25 Médicaments antiémétiques nouveaux. Expired FR1525M (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR869011A FR1525M (fr) 1961-07-25 1961-07-25 Médicaments antiémétiques nouveaux.
FR897802A FR36F (fr) 1961-07-25 1962-05-17 Médicaments antiémétiques nouveaux.
GB2007962A GB994023A (en) 1961-07-25 1962-05-24 Substituted n-(tertiary amino alkyl)benzamides
US210556A US3219528A (en) 1961-07-25 1962-07-17 Compositions for treatment of emesis and behavior disturbances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR869011A FR1525M (fr) 1961-07-25 1961-07-25 Médicaments antiémétiques nouveaux.

Publications (1)

Publication Number Publication Date
FR1525M true FR1525M (fr) 1962-11-16

Family

ID=8760053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR869011A Expired FR1525M (fr) 1961-07-25 1961-07-25 Médicaments antiémétiques nouveaux.

Country Status (2)

Country Link
US (1) US3219528A (fr)
FR (1) FR1525M (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297170A (fr) * 1963-04-04 1900-01-01
US4140769A (en) * 1976-12-23 1979-02-20 Miles Laboratories, Inc. 3-Substituted salicylamides
US4301159A (en) * 1980-06-20 1981-11-17 Shionogi & Co., Ltd. N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
YU46706B (sh) * 1987-09-05 1994-04-05 Hokuriku Pharmaceutical Co. Ltd. Postupak za dobijanje amidnih jedinjenja
IT1216120B (it) * 1988-03-17 1990-02-22 Poli Ind Chimica Spa Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
CH681690A5 (en) * 1990-09-28 1993-05-14 Kali Chemie Pharma Gmbh New metoclopramide salt compsns. with no additives
SE0002531D0 (sv) * 2000-07-05 2000-07-05 Active Biotech Ab Immune Enhancement
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (fr) * 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Analogues d'halobenzamide marqués en tant que produits radiopharmaceutiques multimodaux et leurs précurseurs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691025A (en) * 1951-03-30 1954-10-05 Sterling Drug Inc N-(tertiary-aminoalkyl)-2, 4-disubstituted-benzamides and their preparation
US2691041A (en) * 1953-05-21 1954-10-05 Sterling Drug Inc N-(tertiary-aminoalkyl)-2-substituted-4-nitrobenzamides and their salts
US2819305A (en) * 1956-09-28 1958-01-07 Olin Mathieson Aminoalkylamides of butoxybenzoic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
US3219528A (en) 1965-11-23

Similar Documents

Publication Publication Date Title
FR1325M (fr) Nouveaux aminoacétylenes.
FR1525M (fr) Médicaments antiémétiques nouveaux.
DK103819C (da) Lidsespiraltov.
DK109721C (da) Injektionssprøjte.
DK108290C (da) Injektionssprøjte.
FR1599M (fr) Nouveaux anesthésiques.
FR2380M (fr) Nouveaux tranquillisants.
FR2468M (fr) Nouveaux médicaments antitussifs.
FR1601M (fr) Nouveaux médicaments analgésiques.
FR1526M (fr) Nouveaux médicaments antiémétiques.
FR36F (fr) Médicaments antiémétiques nouveaux.
FR2737M (fr) Nouveaux alcoylthiostéroides.
FR2378M (fr) Nouveaux antibiotiques.
FR1772M (fr) Nouveaux alcoythiostéroides.
FR127M (fr) Médicaments nouveaux pour calcithérapie.
FR2259M (fr) Nouveaux médicaments diurétiques.
FR27M (fr) Nouveaux médicaments anti-hypokaliémiques.
FR2824M (fr) Nouveaux médicaments spécifiques électifs.
FR2519M (fr) Médicament analgésique.
FR3F (fr) Nouveaux médicaments anti-hypokaliémiques.
FR1441M (fr) Médicament gastro-hépato-entérologique.
FR1337M (fr) Médicament antihypokaliémique.
FR1341714A (fr) Nouveaux di-imidazoles
FR1285079A (fr) Nouveaux aminohydroxynitriles cyanéthylés
FR2561M (fr) Polypeptides nouveaux.